Livongo Health, a digital company focused on chronic disease management raised $20 million in Series B funding.

The company will use the capital to further develop its platform and accelerate the adoption of the company's digital diabetes management program, Livongo for Diabetes, among self-insured employers, healthcare providers and payers.

Investors included Kleiner Perkins Caufield & Byers, or KPCB, and also DFJ and previous investor General Catalyst.

Since launching Livongo Health in September 2014, the company has received strong interest in the program and has signed agreements for employees of self-insured employers such as Office Depot, Iron Mountain and multiple Fortune 100 companies. Livongo Health also has agreements in place with large healthcare providers, such as Mission Health System and HealthCare Partners, as well as some of the country's largest payers. It also recently completed a multi-year strategic agreement with Cerner for integration and distribution to its client base.

[See also: Better IT needed in battling diabetes.]

"We are very pleased to receive the support and insight of some of Silicon Valley's premier healthcare investors," said Glen Tullman, CEO of Livongo Health, in a news release. "With thousands of people now using Livongo for Diabetes, it's clear that the best way for people to manage chronic diseases like diabetes is to empower them with real-time, personalized information about their condition. This information improves care, reduces costs and enables people to focus on their lives and not their diseases."

Livongo for Diabetes is the company's initial product offering and is targeted to people with either Type 1 or Type 2 diabetes. It is the first diabetes management program that is completely mobile, digital and personalized to the user, according to the company. It allows people with diabetes to effectively manage important aspects of their illness on their own. It also allows them to easily keep their family members and care team informed in real-time.

Beth Seidenberg, general partner at KPCB, and Emily Melton, Partner at DFJ, will be joining the Livongo Health board of directors.

"The Livongo platform is a powerful disease management ecosystem," Seidenberg said in a statement. "Its ability to collect real-time biometric data, analyze it in the cloud and instantly push down guidance and support to the user is unique in diabetes management."
 
Here's how it works: Each Livongo for Diabetes user receives the company's In Touch blood glucose smartmeter, a proprietary mobile device that is the first cellular-enabled, two-way interactive blood glucose meter. The device captures a user's biometric data and uploads it to a cloud-based inference engine where historical data, clinical rules and predictive modeling are used to convert it into useable information and support that is instantly returned back to the person with diabetes. This data can also be shared with anyone in the user's family or care team, including a Livongo certified Diabetes educator, who can provide real-time feedback and assistance via push notification, text, email or phone. The Livongo program offers unlimited test strips at no extra charge and removes daily hassles like hand-written logbooks, having to connect a traditional glucose meter to a computer with a cable and re-ordering supplies.

[See also: mHealth takes on diabetes.]

"Feedback on the Livongo program from our employees has been phenomenal," Scott Kirschner, director of benefits strategy at Iron Mountain, said in a news release. "As a global company, we look for solutions that can meet the needs of our large, geographically dispersed workforce with wide-ranging health and wellness requirements. For our people with diabetes, we wanted a partner that could marry technology with a high human touch to help them and their physicians better manage their conditions."